Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
T
Taylor McElroy
Researcher
Also affiliated: Duquesne University (2019–2025); National Institute for Occupational Safety and Health (1985); University of Arkansas Medical Center (2018); University of Dental Medicine (1984); University of Florida (2021–2025); Cancer Research Center (1984); Institute on Aging (2021–2025); Arkansas Department of Agriculture (2018); University of Missouri–Kansas City (1984); Columbia College - Missouri (1987); Florida College (2023–2024)
Faculty Researcher
14 h-index
37 pubs
511 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Taylor McElroy's research investigates the physiological and cognitive impacts of various medical treatments and environmental factors. Their work has explored sex differences in frailty among older adults and the toxicities of bisphenol compounds in both nematode and mammalian cells. McElroy has also studied cognitive impairment resulting from chemotherapy agents like docetaxel, doxorubicin, and cyclophosphamide, as well as the neuro-protective potential of piperlongumine in this context. Further investigations have examined the implications of the gut microbiome and depressive-like behaviors following cyclophosphamide, methotrexate, and fluorouracil treatments. The role of mitochondria in neuronal recovery after injury and the effects of simulated galactic cosmic rays on cognitive performance in mice are also areas of focus. McElroy collaborates with researchers including Antiño R. Allen, Pilar Simmons, Taurean Brown, and Fabio Ntagwabira at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 14
- Publications: 37
- Citations: 511
Selected Publications
-
Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment (2026)
-
The adverse effects of chemotherapy on bone mass are not prevented by senolytics (2025)
-
Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior (2023)
-
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment (2022)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Effects of 16O charged-particle irradiation on cognition, hippocampal morphology and mutagenesis in female mice (2021)
-
Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide (2021)
-
Cranial irradiation impairs juvenile social memory and modulates hippocampal physiology (2020)
-
A Bibliometric Review of Artificial Extracellular Matrices Based on Tissue Engineering Technology Literature: 1990 through 2019 (2020)
-
Late Effects of 1H + 16O on Short-Term and Object Memory, Hippocampal Dendritic Morphology and Mutagenesis (2020)
-
A Bibliometric Review of Publications on Oxidative Stress and Chemobrain: 1990–2019 (2020)
-
Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment (2020)
-
Early Effects of Cyclophosphamide, Methotrexate, and 5-Fluorouracil on Neuronal Morphology and Hippocampal-Dependent Behavior in a Murine Model (2019)
-
Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats (2019)
Collaboration Network
Top Collaborators
Antiño R. Allen
University of Arkansas Medical Center
8 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Effects of 16O charged-particle irradiation on cognition, hippocampal morphology and mutagenesis in female mice
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Showing 5 of 8 shared publications
Pilar Simmons
University of Arkansas for Medical Sciences
6 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Showing 5 of 6 shared publications
Taurean Brown
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Fabio Ntagwabira
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Madison Trujillo
University of Arkansas for Medical Sciences (US)
4 shared publications
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Chase Swinton
University of Arkansas for Medical Sciences
2 shared publications
In database
- Effects of 16O charged-particle irradiation on cognition, hippocampal morphology and mutagenesis in female mice
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Vijayalakshmi Sridharan
University of Arkansas for Medical Sciences
2 shared publications
In database
- Effects of 16O charged-particle irradiation on cognition, hippocampal morphology and mutagenesis in female mice
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Christa Corley
University of Arkansas for Medical Sciences
2 shared publications
In database
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Sangam Kandel
University of Arkansas for Medical Sciences
2 shared publications
In database
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Huddoy Walters
University of Arkansas for Medical Sciences (US)
1 shared publication
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Jing Wang
University of Arkansas for Medical Sciences (US)
1 shared publication
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Stephanie D. Byrum
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Frederico Kiffer
University of Arkansas for Medical Sciences (US)
1 shared publication
- Effects of 16O charged-particle irradiation on cognition, hippocampal morphology and mutagenesis in female mice
Jing Wang
University of Arkansas for Medical Sciences (US)
1 shared publication
- Effects of 16O charged-particle irradiation on cognition, hippocampal morphology and mutagenesis in female mice
Marjan Boerma
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of 16O charged-particle irradiation on cognition, hippocampal morphology and mutagenesis in female mice
Similar Researchers
Based on overlapping research topics
Taurean Brown
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Thomas Groves
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Pilar Simmons
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Pharmacological Effects and Toxicity Studies
Mitochondrial Function and Pathology
Chhanda Bose
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Mitochondrial Function and Pathology
Neuroscience and Neuropharmacology Research
Kyle Urquhart
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Plant and animal studies
Fabio Ntagwabira
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research